glp-1 impact on food and beverage sales 2025 report Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Medication Effect on Food

10.1016/j.tibs.2016.09.002 212 YuanT.YangT.ChenH.FuD.HuY.WangJ.et al (2019)

doi:10.4103/0976-3147.102609 78

Oral option needed: Only Semaglutide has an oral form (Rybelsus), though injectables outperform it for weight loss

Demonstration of gut-barrier dysfunction in early stages of non-alcoholic fatty liver disease: a proof-of-concept study

Wegovy is a specific, FDA-approved brand-name drug product, while compounded semaglutide is a customized medication prepared by a licensed pharmacist in an FDA-registered pharmacy

The goal is not simply to reach a stable dose, but to achieve and sustain clinically meaningful weight loss over time